Product Images Norpace Cr

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Norpace Cr NDC 0025-2732 by Pfizer Laboratories Div Pfizer Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - norpace 01

Chemical Structure - norpace 01

The text is not-available as it lacks context and is composed solely of chemical symbols and formulas. It appears to be a diagram of a chemical structure, but without more information, it cannot be interpreted or described.*

G.D. Searle LLC logo - norpace 02

G.D. Searle LLC logo - norpace 02

This text indicates that the distribution of a product is being handled by Pfizer Labs, which is a division of Pfizer Inc. The location of the division is in NY, NY 10017.*

Principle Display Panel - 100 mg Bottle Label - norpace 03

Principle Display Panel - 100 mg Bottle Label - norpace 03

This is a medication with the brand name Norpace® and the active ingredient disopyramide phosphate. The medication comes in a capsule form with each capsule containing 100 mg of the active ingredient. The recommended storage temperature is between 15-30°C (50-86°F), while the permissible temperature range is within 25°C (17°F). The manufacturer is Pfizer Labs and the medication is distributed from New York. The text also includes a product code (NDC 0025-2752-31) and a lot number (PAA164018). No dosage or usage information is provided, and the text contains several typographical errors.*

Principle Display Panel - 150 mg Bottle Label - norpace 04

Principle Display Panel - 150 mg Bottle Label - norpace 04

Store the disopyramide phosphate capsules USP at a temperature of 25°C (17°F). Excursions pemmitied o 15-30°C (50-86°F). Refer to USP Controlled Room Temperature]. The capsules are available in 100 capsules Rx only. Each capsule contains 150 mg of dopytaids bas. See accompanying prescribing information for dosage and use. The containers are distributed by PizerLabs, Dison ofPizer e, Y, NY 10017. The product is made in Japan. The NDC number for this product is 0025-2762-31.*

Principle Display Panel - 100 mg Bottle Label - norpace 05

Principle Display Panel - 100 mg Bottle Label - norpace 05

This is a medication for Norpace® CR, which contains disopyramide phosphate extended-release capsules USP2 with a strength of 100mg. The medication should be stored in a cool, dry, tight and chi-resistant container with temperature excursions permitted to 15-30°C (50-86°F). Dosage and usage information can be found in the accompanying information. The medication is distributed by Pfizer and made in Japan. The product is contained in a bottle with 100 capsules, and lot/expiry information and GTIN number are not available from the given text.*

Principle Display Panel - 150 mg Bottle Label - norpace 06

Principle Display Panel - 150 mg Bottle Label - norpace 06

This text provides some storage information as well as some dosage and use instructions for a medication called Norpace CR. Each capsule is said to contain 150 mg of disopyramide phosphate and the medication comes in extended-release capsules. The text also includes contact information for Pfizer Labs.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.